REGISTERED NUMBER: 09311140 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2024

FOR

STRATEGIC HEALTHCARE SERVICES LIMITED

Page

Company Information

1

Balance Sheet

2

Statement of Changes in Equity

3

Notes to the Financial Statements

4

DIRECTORS:

Dr R Jayaswal

M J Reidy

Mrs E Taylor

REGISTERED OFFICE:

Hurstwood Court

The Gatehouse

Kay Street

Summerseat

Bury

BL9 5PE

REGISTERED NUMBER:

09311140 (England and Wales)

ACCOUNTANTS:

Donachie Chartered Accountants

2nd Floor

Templeton House

62 Templeton Street

Glasgow

G40 1DA

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

-

-

Investments

6

200

160

200

160

CURRENT ASSETS

Debtors

7

821

-

Cash at bank

2,052

4,172

2,873

4,172

CREDITORS

Amounts falling due within one year

8

2,200

4,161

NET CURRENT ASSETS

673

11

TOTAL ASSETS LESS CURRENT LIABILITIES

873

171

CAPITAL AND RESERVES

Called up share capital

9

100

100

Retained earnings

773

71

SHAREHOLDERS' FUNDS

873

171

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17th September 2025 and were signed on its behalf by:

M J Reidy - Director

Called up

share

Retained

Total

capital

earnings

equity

£

£

£

Balance at 1st January 2023

100

6,615

6,715

Changes in equity

Dividends

-

(596,400

)

(596,400

)

Total comprehensive income

-

589,856

589,856

Balance at 31st December 2023

100

71

171

Changes in equity

Dividends

-

(431,220

)

(431,220

)

Total comprehensive income

-

431,922

431,922

Balance at 31st December 2024

100

773

873

1.	STATUTORY INFORMATION

Strategic Healthcare Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements

The financial statements contain information about Strategic Healthcare Services Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

33% on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments

Financial instruments are classified and accounted for as financial assets, financial liabilities or equity instruments, according to the substance of the contractual arrangement.

Financial instruments which are assets are stated at cost less any provision for impairment. Financial liabilities are stated at principal capital amounts outstanding at the period end. Issue costs relating to financial liabilities are deducted from the outstanding balance and are amortised over the period to the due date for repayment of the financial liability.

An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. A financial liability is any contractual arrangement for an entity to deliver cash to the holder of the associated financial instrument.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1st January 2024

and 31st December 2024

76,714

AMORTISATION

At 1st January 2024

and 31st December 2024

76,714

NET BOOK VALUE

At 31st December 2024

-

At 31st December 2023

-

5.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1st January 2024

and 31st December 2024

1,778

DEPRECIATION

At 1st January 2024

and 31st December 2024

1,778

NET BOOK VALUE

At 31st December 2024

-

At 31st December 2023

-

6.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1st January 2024

160

Additions

40

At 31st December 2024

200

NET BOOK VALUE

At 31st December 2024

200

At 31st December 2023

160

The company's investments at the Balance Sheet date in the share capital of companies include the following:

SHS Partners Surgical Limited

Registered office: Huntswood Court, New Hall Hey Road, Rossendale, Lancashire BB4 6HH.

Nature of business: Provision of Healthcare Services.

%

Class of shares:

holding

Ordinary Shares of £1 each

100.00

2024

2023

£

£

Aggregate capital and reserves

1,065,939

1,691,383

(Loss)/profit for the year

(303,224

)

1,220,007

SHS Pathology Limited

Registered office: Huntswood Court, New Hall Hey Road, Rossendale, Lancashire BB4 6HH.

Nature of business: Histology Testing and Research Support.

%

Class of shares:

holding

Ordinary shares of £1 each

100.00

2024

2023

£

£

Aggregate capital and reserves

50,027

223,488

Profit for the year

26,539

112,318

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Amounts owed by group undertakings

821

-

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Amounts owed to group undertakings

-

2,001

Accruals and deferred income

2,200

2,160

2,200

4,161

9.	CALLED UP SHARE CAPITAL

Allotted, Issued and fully paid:

Number:

Class:

Nominal

2021

2020

Value:

£

£

20

Ordinary A Shares

£1

20

20

20

Ordinary B Shares

£1

20

20

20

Ordinary C Shares

£1

20

20

20

Ordinary E Shares

£1

20

20

20

Ordinary F Shares

£1

20

20

100

100

The holder of an 'A', 'B', 'C', 'E' and 'F' Ordinary share is entitled on a show of hands to one vote and on a poll to one vote for every 'A', 'B', 'C', 'E' and 'F' Ordinary share of which he or she is the holder.

The holder of each class of Ordinary share is entitled to participate in dividends which the company determines to distribute in respect of any financial year. Differential rates of dividends can be declared on each class of share.

10.	RELATED PARTY DISCLOSURES

During the year, total dividends of £323,220 (2023 - £392,400) were paid to the directors .

During the year, SHS Partners Surgical Limited, a company in which Strategic Healthcare Services Limited is a 100% shareholder paid expenses on its behalf, totalling £2,178 (2023 - £2,001). At the year end the balance due from / to SHS Partners Surgical Limited is £821 (2023 - £2,001).